Gecina successfully places a 500-million euro bond issue with a 15-year maturity at 1.625% and launches a Tender Offer on three of its outstanding series of notes

Alongside this, Gecina has launched a Tender Offer on three of its outstanding series of notes, with an average maturity of four years and an average coupon of 2.15%.

These operations will enable the Group to once again extend the average maturity of its debt, under favorable financial conditions, and to continue building an optimal credit schedule.

This bond issue was up to five times oversubscribed by a top-tier base of pan-European investors, confirming the market's confidence in Gecina's credit rating.

BNP Paribas, Crédit Agricole CIB, CM-CIC, HSBC, Natixis, NatWest Markets and Société Générale were the bookrunners for this issue.

Gecina has launched a Tender Offer, which will close on June 3, 2019, on three of its outstanding series of notes:

• €500,000,000 1.75 per cent. Notes due 30 July 2021 and which €185,800,000 is currently outstanding;
• €300,000,000 2.875 per cent. Notes due 30 May 2023 and which €210,300,000 is currently outstanding; and
• €500,000,000 2.00 per cent. Notes due 17 June 2024 and which €500,000,000 is currently outstanding.

BNP Paribas and Société Générale are the bookrunners for this Tender Offer.

Gecina is rated A- / outlook stable by Standard & Poor’s and A3 / outlook stable by Moody’s.

This press release and the information contained herein do not constitute an offer to purchase nor a solicitation to sell the notes referred to above, nor an invitation to participate to the Tender Offer.

The distribution of this press release may be restricted in some countries and be subject to specific regulations and persons in possession of this press release should inform themselves about and comply with any applicable restrictions.

Not for distribution in the United States, Australia, Canada or Japan. This press release does not constitute an offer of securities in the United States or in any other country. The bonds may not be offered or sold in the United States of America unless they are registered or exempt from registration under the U.S. Securities Act of 1933 (amended). Gecina does not intend to register all or part of the offering in the United States or to conduct a public offering in the United States.